Influence of Different Families of Commercial Antibiotics on Controlling Nosocomial Infections

Main Article Content

Mohamed Abdel-Raouf
Hisham M. Aldeweik
Mohamed S. Albannan
Mohamed M. Zaki
Ahmed E. Abdelkader
Dalia Moemen

Abstract

Aims: Nosocomial infection (NI) is one of the most important problems facing the world. This work is dedicated to investigating the prevalence rates of NI in addition to estimating the minimum inhibition concentration (MIC) of commercial antibiotics on isolated bacteria in order to determine the most diluted antibiotic that performed well with more efficiency and minimal toxicity.

Place and Duration of Study: Gastroenterology Surgical Center, Mansoura University, Mansoura, Egypt, between July 2017 and July 2018.

Methodology: This study included 368 different samples (urine, stool, sputum and surgical wounds) from 100 patients A total of 15 commercial antibiotics selected from seven families having different mode of action were used.

Results: Our findings demonstrated that the highest prevalence rate of NI was detected in K. pneumoniae (40%, n=56) followed by MRSA (22.85%, n=32), E. coli (20%, n=28), P. mirabilis (7.85%, n=11), P. putida (5%, n=7) and finally P. aeruginosa (4.3%, n=6). In addition, the results showed variable MICs of various antibiotics on isolated bacteria associated with NI.

Conclusion: Interestingly, our findings showed that quinolones family had the highest impact on all types of isolated bacteria associated with nosocomial infections.

Keywords:
Nosocomial infections, antibiotics, K. pneumoniae, MRSA, E. coli, P. mirabilis, P. putida, P. aeruginosa.

Article Details

How to Cite
Abdel-Raouf, M., Aldeweik, H. M., Albannan, M. S., Zaki, M. M., Abdelkader, A. E., & Moemen, D. (2019). Influence of Different Families of Commercial Antibiotics on Controlling Nosocomial Infections. South Asian Journal of Research in Microbiology, 4(2), 1-8. https://doi.org/10.9734/sajrm/2019/v4i230103
Section
Original Research Article

References

Jain A, Singh K. Recent advances in the management of nosocomial infections. JK Science. 2007;9(1):3-8.

Struelens MJ. The epidemiology of antimicrobial resistance in hospital acquired infections: Problems and possible solutions. Bmj. 1998;317(7159):652-4.

Ducel G, Fabry J, Nicolle L, Organization WH. Prevention of hospital- acquired infections: A practical guide; 2002.

Inweregbu K, Dave J, Pittard A. Nosocomial infections. Continuing Education in Anaesthesia, Critical Care & Pain. 2005;5(1):14-7.

Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. American journal of infection control. 2007;35(10):S165-S93.

Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. The Lancet infectious diseases. 2008;8(2):101-13.

Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical care medicine. 2006; 34(6):1589-96.

Valgas C, Souza SMd, Smânia EF, Smânia Jr A. Screening methods to determine antibacterial activity of natural products. Brazilian Journal of Microbiology. 2007;38(2):369-80.

Pittet D, Allegranzi B, Storr J, Nejad SB, Dziekan G, Leotsakos A, et al. Infection control as a major World Health Organization priority for developing countries. Journal of Hospital Infection. 2008;68(4):285-92.

Custovic A, Smajlovic J, Hadzic S, Ahmetagic S, Tihic N, Hadzagic H. Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Materia Socio-Medica. 2014;26(1):7.

Khan HA, Ahmad A, Mehboob R. Nosocomial infections and their control strategies. Asian pacific journal of tropical biomedicine. 2015;5(7):509-14.

Shaikh JM, Devrajani BR, Shah S, Akhund T, Bibi I. Frequency, pattern and etiology of nosocomial infection in intensive care unit: An experience at a tertiary care hospital. J Ayub Med Coll Abbottabad. 2008;20(4):37-40.

Borg MA, De Kraker M, Scicluna E, van de Sande-Bruinsma N, Tiemersma E, Monen J, et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries. Journal of Antimicrobial Chemotherapy. 2007;60(6): 1310-5.

Lombardi G, Luzzaro F, Docquier J-D, Riccio ML, Perilli M, Colì A, et al. Nosocomial infections caused by multidrug-resistant isolates of Pseudomonas putida producing VIM-1 metallo-β-lactamase. Journal of Clinical Microbiology. 2002;40(11): 4051-5.

Kim SE, Park SH, Park HB, Park KH, Kim SH, Jung SI, et al. Nosocomial Pseudomonas putida bacteremia: High rates of carbapenem resistance and mortality. Chonnam Medical Journal. 2012; 48(2):91-5.

Ayub S, Fatima B, Baqir S, Naqvi S, Sheikh D, Ali SM, et al. Amoxicillin and tetracycline activity against Staphylococcus aureus and proteus mirabilis. Int J Curr Pharm Res. 2015; 7(4):49-52.

Mustafa MH, Khandekar S, Tunney MM, Elborn JS, Kahl BC, Denis O, et al. Acquired resistance to macrolides in Pseudomonas aeruginosa from cystic fibrosis patients. European Respiratory Journal. 2017;49(5):1601847.

Maehara Y, Shirabe K, Kohnoe S, Emi Y, Oki E, Kakeji Y, et al. Impact of intra-abdominal absorbable sutures on surgical site infection in gastrointestinal and hepato-biliary-pancreatic surgery: Results of a multicenter, randomized, prospective, phase II clinical trial. Surgery today. 2017; 47(9):1060-71.

Aga E, Keinan-Boker L, Eithan A, Mais T, Rabinovich A, Nassar F. Surgical site infections after abdominal surgery: Incidence and risk factors. A prospective cohort study. Infectious Diseases. 2015; 47(11):761-7.

Baker AW, Dicks KV, Durkin MJ, Weber DJ, Lewis SS, Moehring RW, et al. Epidemiology of surgical site infection in a community hospital network. Infection Control & Hospital Epidemiology. 2016; 37(5):519-26.